e-learning
resources
Vienna 2012
Wednesday, 05.09.2012
COPD exacerbation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relation between metabolic syndrome and acute exacerbation of COPD
H. Ben Abdelghaffar, E. Tangour, S. Fenniche, L. El Fekih, D. Greb, I. Akrout, H. Hassene, W. Ben hamad, H. Kammoun, D. Belhabib, M.L. Megdiche (Ariana, Tunisia)
Source:
Annual Congress 2012 - COPD exacerbation
Session:
COPD exacerbation
Session type:
Poster Discussion
Number:
4826
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Ben Abdelghaffar, E. Tangour, S. Fenniche, L. El Fekih, D. Greb, I. Akrout, H. Hassene, W. Ben hamad, H. Kammoun, D. Belhabib, M.L. Megdiche (Ariana, Tunisia). Relation between metabolic syndrome and acute exacerbation of COPD. Eur Respir J 2012; 40: Suppl. 56, 4826
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Mechanisms of exacerbation of respiratory symptoms in patients with metabolic syndrome
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Metabolic syndrome and chronic diseases in COPD
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Role of testosterone in acute exacerbation of chronic obstructive pulmonary disease: Relationship with severity indices
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Metabolic syndrome in chronic obstructive pulmonary disease
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Relationship between systemic inflammation and rhythmicity of acute exacerbations of COPD
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
Source: International Congress 2014 – Comorbidities
Year: 2014
Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Determinants of re-hospitalizations due to acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Acute phase reactants as predictors for hospital mortality in acute respiratory failure due to COPD exacerbation
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Relationship between the severity of dyspnea and pulmonary function in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Metabolic syndrome and COPD
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
Impact of anemia on dyspnea on exertion and exercise tolerance in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Exercise assessment in different diseases
Year: 2011
Time course of serum leptin and markers of systemic inflammation during acute hypercapnic respiratory failure in patients with COPD and obesity-hypoventilation syndrome (OHS)
Source: Eur Respir J 2006; 28: Suppl. 50, 394s
Year: 2006
Regulation of ghrelin on appetite in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept